These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6180687)

  • 41. Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?
    Kim Y; Flamm A; ElSohly MA; Kaplan DH; Hage RJ; Hamann CP; Marks JG
    Dermatitis; 2019; 30(3):183-190. PubMed ID: 31045932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contact dermatitis due to poison ivy, oak, and sumac.
    Sanders SH; Taub SJ
    Eye Ear Nose Throat Mon; 1965 Oct; 44(10):99-100. PubMed ID: 4220541
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.
    Kalish RS
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):108S-111S. PubMed ID: 1693644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol.
    Stampf JL; Benezra C; Byers V; Castagnoli N
    J Invest Dermatol; 1986 May; 86(5):535-8. PubMed ID: 2943824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desensitization to poison ivy.
    GROSS ER
    Med Times; 1956 Sep; 84(9):921-3. PubMed ID: 13368853
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyposensitization against Rhus dermatitis.
    KLIGMAN AM
    AMA Arch Derm; 1958 Jul; 78(1):47-72. PubMed ID: 13544625
    [No Abstract]   [Full Text] [Related]  

  • 47. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
    Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
    Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and treatment of poison ivy dermatitis.
    Briant D; Brouder G
    Nurse Pract; 1983; 8(7):13, 16, 19 passim. PubMed ID: 6225038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral hyposensitization in allergic contact dermatitis.
    Sjövall P; Christensen OB
    Semin Dermatol; 1990 Sep; 9(3):206-9. PubMed ID: 2206920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patch testing versus history in poison ivy/oak dermatitis.
    Zhai H; Chang YC; Singh M; Maibach HI
    Contact Dermatitis; 1997 Apr; 36(4):226. PubMed ID: 9165209
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation and Management of Toxicodendron Dermatitis in the Emergency Department: A Review of Current Practices.
    Argo KA; Massey RC; Luth SK; Herrington JM; Lane AQ; Murray KA
    Wilderness Environ Med; 2023 Sep; 34(3):388-392. PubMed ID: 37120383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dermoscopy of black-spot poison ivy.
    Rader RK; Mu R; Shi H; Stoecker WV; Hinton KA
    Dermatol Online J; 2012 Oct; 18(10):8. PubMed ID: 23122015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of hyposensitization on atopic dermatitis in dogs.
    Willemse A; Van den Brom WE; Rijnberk A
    J Am Vet Med Assoc; 1984 May; 184(10):1277-80. PubMed ID: 6376442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance.
    Färm G
    Acta Derm Venereol Suppl (Stockh); 1998; 201():1-42. PubMed ID: 9833065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poison ivy, oak, and sumac dermatitis.
    Lee NP; Arriola ER
    West J Med; 1999; 171(5-6):354-5. PubMed ID: 10639874
    [No Abstract]   [Full Text] [Related]  

  • 56. Urushiol Compounds Detected in Toxicodendron-Labeled Consumer Products Using Mass Spectrometry.
    Zhang AJ; Aschenbeck KA; Law BF; BʼHymer C; Siegel PD; Hylwa SA
    Dermatitis; 2020; 31(2):134-139. PubMed ID: 32168145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide:hapten conjugate.
    Gelber C; Gemmell L; McAteer D; Homola M; Swain P; Liu A; Wilson KJ; Gefter M
    J Immunol; 1997 Mar; 158(5):2425-34. PubMed ID: 9036993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects.
    Johnson RA; Haer H; Kirkpatrick CH; Dawson CR; Khurana RG
    J Allergy Clin Immunol; 1972 Jan; 49(1):27-35. PubMed ID: 4257103
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis of compounds structurally related to poison ivy urushiol. 4. 3-(1-Alkyl)alkylcatechols of varying side-chain shape and flexibility.
    Kurtz AP; Dawson CR
    J Med Chem; 1971 Aug; 14(8):733-7. PubMed ID: 4107135
    [No Abstract]   [Full Text] [Related]  

  • 60. [Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study].
    Bagot M; Terki N; Bacha S; Moyse D; Suck C; Revuz J
    Ann Dermatol Venereol; 1999; 126(6-7):502-4. PubMed ID: 10495859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.